ImmunityBio (IBRX) is back in focus after its stock surged 282.7% year to date, as investors weigh speculation around Anktiva ...
One man who isn't swayed is Japan's richest investment mogul, SoftBank CEO Masayoshi Son. Speaking at his company's annual ...
The U.S. has announced 25% duties on many imports from Brazil, while unveiling a broader-than-expected list of exemptions, ...
Alumasc (LSE:ALU) delivered a resilient financial performance for the year ended 30 June 2026 despite challenging conditions across its commercial construction markets, with a sharp increase in its ...
A number of stocks fell in the afternoon session after TSMC paired topline strength with a free cash flow-compressing capital ...
Former Intel CEO Pat Gelsinger called out his predecessors for their role in the chipmaker's decline. Gelsinger questioned why Intel was led by executives without a strong technical background.
Oracle Corp.’s ambitions to dominate the artificial intelligence buildout are running into a key hurdle: funding a spending spree without further damaging its credit standing.Most Read from ...
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has completed its acquisition of SPR Therapeutics, Inc. (SPR), a privately held medical technology company and ...
OUST targets EBITDA breakeven through strong revenue growth, steady margins and cost discipline, with profitability ...
Spooked Russian billionaires are hurriedly moving their money out of the country as President Vladimir Putin’s problems mount ...
Warren Buffett giving a chunk of his fortune to 70 million American children would be a "fitting legacy" for the investor, ...
ALLO-316 Achieved a 31% Confirmed Response Rate with the Recommended Phase 2 Regimen in Patients with Stage IV Renal Cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results